« Back to News
ICAP to Support Expansion of Option B+ for Pregnant Women in Cameroon
ICAP has been awarded funding from the Centers for Disease Control and Prevention (CDC) through PEPFAR to provide technical assistance to expand and improve HIV services for the prevention of mother-to-child transmission (PMTCT) in Cameroon.
ICAP will partner with Cameroon’s Ministry of Health to expand the option B+ strategy to achieve scale up of use of antiretroviral therapy for pregnant women and their families as well as enhancing the quality of the programs. The approach will aim to: strengthen community structures to increase HIV awareness and improve retention in care; enhance use of data to guide program improvement; and build capacity at all levels of the health system to coordinate HIV activities across the continuum of care.
“This is an important opportunity to ensure that HIV-infected women, their children and families members are identified early, initiated on treatment, and retained in care,” said Dr. Elaine Abrams, the project’s principal investigator and senior research director at ICAP.
This project builds on ICAP’s recent contributions to maternal and child health in Cameroon and its longstanding commitment to the design, implementation and monitoring of family-focused HIV prevention, care and treatment programs.